Aerocrine: Interim report January – March 2012
SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News:
Aerocrine (STO:AEROB):
January – March 2012
- Global Net sales grew by 76% to SEK 39.0m (22.2). Adjusted for currency fluctuations, net sales rose by 72%
- The worldwide number of NIOX MINO® repeat tests sold increased by a total of 47% and for clinical use in the US by 112%